Divi's Laboratories
Best Pharmaceutical Company Hyderabad, India | Divis Pharma Industry.
Launch date
Employees
Market cap
€18.0b
Enterprise valuation
€17.5b (Public information from Sep 2024)
Share price
INR5481 DIVISLAB.NS
Hyderabad Telangana (HQ)
Financials
Estimates*
| INR | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 52.9b | 68.6b | 88.0b | 77.7b | 78.0b |
| % growth | - | 30 % | 28 % | (12 %) | - |
| EBITDA | 19.6b | 29.3b | 40.0b | 27.1b | 25.4b |
| % EBITDA margin | 37 % | 43 % | 45 % | 35 % | 33 % |
| Profit | 13.8b | 19.8b | 29.6b | 18.2b | 16.0b |
| % profit margin | 26 % | 29 % | 34 % | 23 % | 21 % |
| R&D budget | 111m | 150m | 203m | 301m | 350m |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | INR358m | Post IPO Equity | |
| Total Funding | - | ||
Recent News about Divi's Laboratories
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.